ArticleSurgery today2026
Outcomes after esophageal perforation: A tertiary referral center series.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEsophageal perforation (EP) is a rare, life-threatening condition associated with high morbidity and mortality. This study aimed to evaluate the clinical factors associated with mortality and to assess the predictive performance of commonly used clinical severity scoring systems, including the Pittsburgh Severity Score (PSS), ASA physical status classification, and quick Sequential Organ Failure Assessment (qSOFA) score, in patients with EP.
methodsA retrospective analysis of patients treated for EP at a tertiary referral center between 2023 and 2025 was performed. Survivors and non-survivors were compared using non-parametric tests. Effect sizes were calculated using Cliff's delta and Cramér's V. Receiver operating characteristic (ROC) analysis was used to evaluate the discriminatory performance of the PSS for mortality.
resultsEleven patients were included in the study. Thoracic imaging findings (pneumomediastinum and pleural effusion) and clinical indicators of systemic deterioration showed large effect sizes for mortality. PSS was the only variable significantly associated with mortality (p = 0.033) and demonstrated a large effect size (Cliff's δ = -0.80). An ROC analysis showed excellent discriminatory performance (AUC = 0.90), with a cutoff value of 6.5 predicting mortality with 100% sensitivity and 67% specificity. The overall mortality rate was 45.5%.
conclusionsEarly recognition and appropriate managementof esophageal perforation are crucial for improving clinical outcomes. Among the evaluated severity scoring systems, the Pittsburgh Severity Score demonstrated the strongest association with mortality and excellent discriminative performance. These findings suggest that the PSS is a practical tool for early risk stratification and management guidance in high-risk patients with esophageal perforation.
Indexed as
Identifiers
42525084What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.